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STUDY PROTOCOL

Open Access

Simulation modelling as a tool for
knowledge mobilisation in health policy
settings: a case study protocol
L. Freebairn1,2,3* , J. Atkinson2, P. Kelly1,2,4, G. McDonnell2,5 and L. Rychetnik2,3

Abstract
Background: Evidence-informed decision-making is essential to ensure that health programs and services are effective
and offer value for money; however, barriers to the use of evidence persist. Emerging systems science approaches and
advances in technology are providing new methods and tools to facilitate evidence-based decision-making. Simulation
modelling offers a unique tool for synthesising and leveraging existing evidence, data and expert local knowledge to
examine, in a robust, low risk and low cost way, the likely impact of alternative policy and service provision
scenarios. This case study will evaluate participatory simulation modelling to inform the prevention and management
of gestational diabetes mellitus (GDM). The risks associated with GDM are well recognised; however, debate remains
regarding diagnostic thresholds and whether screening and treatment to reduce maternal glucose levels reduce the
associated risks. A diagnosis of GDM may provide a leverage point for multidisciplinary lifestyle modification
interventions. This research will apply and evaluate a simulation modelling approach to understand the complex interrelation
of factors that drive GDM rates, test options for screening and interventions, and optimise the use of evidence to inform
policy and program decision-making.
Methods/Design: The study design will use mixed methods to achieve the objectives. Policy, clinical practice and research
experts will work collaboratively to develop, test and validate a simulation model of GDM in the Australian Capital Territory
(ACT). The model will be applied to support evidence-informed policy dialogues with diverse stakeholders for the
management of GDM in the ACT. Qualitative methods will be used to evaluate simulation modelling as an evidence
synthesis tool to support evidence-based decision-making. Interviews and analysis of workshop recordings will focus
on the participants’ engagement in the modelling process; perceived value of the participatory process, perceived
commitment, influence and confidence of stakeholders in implementing policy and program decisions identified in
the modelling process; and the impact of the process in terms of policy and program change.
Discussion: The study will generate empirical evidence on the feasibility and potential value of simulation modelling
to support knowledge mobilisation and consensus building in health settings.
Keywords: Health systems, Participatory simulation modelling, Gestational diabetes mellitus, Group model building,
Evaluation, Knowledge mobilisation
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Background
Health systems are under continual pressure to provide
accessible and effective health services within limited
slow growing or reducing budgets. In this context, decisions regarding the best investment of health funds need
to be well informed, reviewed regularly and aimed at
achieving the greatest health gain for the investment.
The divide between research and health system actions
has been frequently recognised [1–3]. Knowledge derived
from research and experience will be of little benefit unless
it is utilised and its success monitored [1]. There is a need
to bridge the gap between the increasingly sophisticated
research on using evidence and practitioner knowledge to
inform practice and policy and the pragmatic nature of
agency decision-making for strategies and actions [2].
Advances in technology have led to increased adoption
of tools and methods aimed at integrating diverse evidence
sources to inform decision-making [4, 5]. However, rigorous assessment of the value and utility of these methods
and tools is required prior to them being more generally
adopted for evidence-based decision support. The application of systems science and simulation modelling to the
decision-making process is an innovative area with great
potential value for those responsible for allocating scarce
resources [6].

What are the challenges of evidence-informed
policymaking?

Evidence-informed policy decisions are essential to ensure
that health intervention programs and service plans are
likely to be effective and offer value for money. However,
barriers to the use of evidence to inform decision-making
remain [7] and the use of published research to inform
policy development is often limited [8]. Descriptive evidence and analytical studies are used to describe issues and
inform priorities; however, evidence on the implementation
and impact of interventions is less commonly used to inform program planning decisions and strategic actions [7].
In some cases, program decision-making can be driven by
“informed guesswork, expert hunches, political and other
imperatives” [9].
To address this, evidence provided to policymakers needs
to be in a form that is useful to them [10–12]. Policymakers
require synthesised and localised data that contrasts and
prioritises policy options, demonstrates effectiveness of interventions, demonstrates the need for a policy response,
demonstrates cost effectiveness of actions, reflects the level
of public support for a particular issue and personalises the
problem [12, 13]. In addition, policy and program decisionmaking processes are rarely linear. They are frequently
iterative processes and are influenced by a range of inputs
such as political environment, budget constraints, resources, values, available expertise and ethics [7, 12, 14, 15].
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Even when research evidence is considered, as in public
health policy development for the prevention of chronic
disease [2], this evidence often points to a large range of
risk factors that contribute to the problem, including
broader social determinants of health. Our lack of understanding about how these risk factors interact, and which
are the most important, have resulted in the development
of more comprehensive, cross-sectoral strategies to tackle
complex or ‘wicked’ problems [5]. However, this approach
may not represent the most efficient or effective approach
to reducing disease burden at the population level. Rather,
it may act to spread finite resources less intensively over a
greater number of programs and initiatives, diluting the
potential impact of investment [5].
Knowledge mobilisation to support evidence-based
decision-making

The term knowledge mobilisation (KM) is used to refer
to a range of active approaches deployed to encourage
the creation and sharing of research-informed knowledge [2]. The number of terms used to describe KM
activities is large [16] and have been widely debated.
These terms include knowledge translation, knowledge
transfer, knowledge to action, knowledge exchange,
knowledge interaction, etc. [2]. This multiplicity of terms
can be a barrier to clear communication in this field [2].
In this research, the term KM is preferred as it reflects
that the process of producing and applying knowledge in
the health sector is non-linear and iterative. KM can involve a number of activities, including capacity building,
advocacy, implementation, research and evaluation [17].
Not all of these activities are applied in every KM project
[17] and they can be applied in different orders; however,
they share the common function of generating and sharing research-informed knowledge [2].
KM strategies have been applied to a range of issues,
including the quality and effectiveness of health services,
addressing policy questions (for example, mapping health
inequity and healthcare disparities), and addressing managerial and organisational issues such as the composition of
multidisciplinary teams and the costs and consequences of
different service models [2, 18]. A key strategy of KM is the
production of good quality, synthesised evidence [9] such
as scoping reviews, systematic reviews, meta analyses and
research summaries highlighting key findings for decisionmakers [9, 10].
Traditional methods of KM via evidence synthesis have
made a valuable contribution; however, they have a number
of characteristics that limit their utility as decision support
methods for complex policy questions. Firstly, systematic
reviews and meta-analyses focus on clear and specific questions and therefore have a narrow focus of investigation
and limited potential to examine complex questions
[11, 19]. Secondly, these methods frequently exclude
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qualitative evidence, and when qualitative evidence is
included it is not used to answer the primary research
question but only to answer supportive questions such
as whether an intervention was acceptable to consumers
[19]. Thirdly, these methods produce static overviews of
the evidence and policy options that are passively provided
to decision-makers, leaving them to interpret that evidence in their localised context and to navigate complexity
and uncertainty as they weigh up options for responding
to the problem [20].
While there are many KM approaches and techniques,
the evaluation of their use is still in its infancy [2, 21].
The limited focus on evaluation of the effectiveness of
KM methods, including systems-based ones, has been
attributed to the challenges associated with the evaluation task [2], including the methodological challenges
of conducting rigorous evaluations. It can be difficult to
measure impact, to attribute impact to different strands
of the activity in a complex environment, and to minimise
the evaluation reporting burden on stakeholders [2].
Systems approaches to knowledge mobilisation

There are acknowledged synergies between KM and systems science [21]. Systems science methods have emerged
as an effective analytical approach with the capacity to
examine both complex health problems and the context
in which they are embedded [6, 22, 23]. Systems science
can be used to map health system components and their
interactions; synthesise evidence, examine and compare
the potential outcomes of interventions; and guide more
efficient investment and conscientious disinvestment of
resources [5]. As practical systems-based KM tools and
strategies emerge, their efficacy needs to be evaluated and
this knowledge to be shared [2, 21].
Systems approaches recognise the highly contextualised
nature of health services and communities and, therefore,
evidence to inform decision-makers is unlikely to be in the
form of prescriptive statements of ‘what works’ [24].
Rather, evidence from a systems-thinking perspective
will suggest the range of strategies that will have different types of effects for different groups under certain
conditions. Building this type of evidence base will involve undertaking diverse methodologies, including the
use of case studies investigating the efficacy of using
systems techniques to inform decision-making [24].
Research methods in prevention science have traditionally employed a reductionist approach focusing on the detail of each component of the system. For example, many
studies focus on the design, measurement and analysis of
specific interventions for specific target groups. These
studies have contributed and will continue to contribute
significantly to understanding the effectiveness of prevention interventions, gaining knowledge about direct causal
relationships and understanding components of complex
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systems [6, 25]. However, this approach can result in a
failure to achieve understanding of the broader system
behaviour influencing prevention problems and can
hinder insights that may be critical for effective policy
and program decision-making [25]. Traditional statistical
methods have difficulty accounting for delays between
cause and effect, non-linear relationships and unanticipated consequences of interventions [23].
Applying a systems approach through dynamic simulation modelling can provide a method to map, visualise and
quantify a complex system, to promote discussion among
stakeholders [26], and to identify points of high leverage for
intervening. Leverage points are those places in a system
where a small shift can create a large impact [27]. Leverage
points are difficult to identify in complex systems using
traditional reductionist research methods which examine
relationships between specific elements of the system in
isolation [28–30]. It is also difficult to identify the direction
of shift required to obtain the desired outcome without
comprehensive analysis and understanding of the system
and its behaviour [27, 31]. Unanticipated consequences of
interventions can have profound and negative impacts
[31, 32], and can lead to policy resistance in which the
intended positive impact of the intervention is counteracted by system responses to the intervention itself [32].
Dynamic simulation models allow for rapid integration
and use of new evidence for policy analysis, make tradeoffs of policy options explicit, and act as a vehicle for advancing controversial, contested and value-laden debates
[5, 31, 33]. Their use to explore the implications of policy
options can give rise to policy scenarios that have not previously been considered [5].
System dynamics modelling has been used as a tool to
represent disease prevalence, risk factors and local context
and to simulate the health outcomes of interventions, thus
facilitating the alignment of prevention efforts by a range
of community stakeholders [34]. For example, Loyo et al.
[35] used a stakeholder engagement process to develop a
system dynamics model to simulate the impact of various
interventions in chronic disease outcomes. The model was
used to illustrate which interventions were most effective
leverage points in the local context/system and therefore
to align and mobilise prevention efforts of community
stakeholders [35].
Participatory modelling processes, such as the one described by Loyo et al. [35], provide an opportunity to
understand and develop efficient solutions in the health
sector [36, 37]. Participatory modelling, firstly, helps community stakeholders understand how multiple variables,
factors and interventions interact. Secondly, simulation
modelling can test the potential impact of programs and
policies in the ‘safety’ of a virtual environment before they
are implemented, saving time, effort, costs and resources.
Thirdly, modelling demonstrates potential secondary and
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tertiary effects (and even unintended consequences) of
intervention strategies. Fourthly, modelling can guide and
prioritise data collection and facilitate dialogue among
stakeholders [36].
The process of participatory simulation modelling involves engaging multidisciplinary stakeholders in a
group model-building process and can be used in conjunction with a number of modelling methods [31, 37, 38]. The
value of this engagement is the development of a shared
mental model of the causal pathways and potential intervention points in the system [39]. A participatory modelling
approach enhances stakeholder knowledge and understanding of the system and its dynamics in varying conditions. It
identifies and clarifies complex and contested real world
problems [33] and the impact of solutions, therefore facilitating the development of action statements based on the
evidence [39, 40]. The involvement of key decision-makers
in the model development and validation increases their
sense of ownership and confidence that the model is valid
for their local context. They are therefore more likely to
draw on the outputs to inform decisions about priority interventions and policies [23, 37, 39, 41].
Important gaps in knowledge

The application of systems thinking to health improvement is acknowledged as an ongoing challenge [42, 43].
Stakeholder engagement and involvement in the modelling process has been particularly lacking, resulting in
unsuccessful projects [42] and a reluctance from ‘nonresearchers’ to use models as a decision support tool
[33]. A systematic review of the use of simulation modelling to inform surgical patient flow processes found
that only half of publications stated that they had produced
a model to inform policymakers and health service
managers and only 26% actually included policymakers
and health service managers in the simulation modelling process [44]. Where policymakers have been included in the simulation modelling process there
remains an absence of rigorous analysis of their perspectives on the utility of the model, their learning relating to
the development and use of the model, and their commitment to implement the findings of the model [5, 37].
Relationships and collaborations are routinely identified as a key factor in systems approaches [45] and this
is particularly true for participatory modelling processes.
Important elements for implementing successful systems
thinking to address complex issues include the formation of networks and teams, distributed leadership, and
strong and effective communication and feedback mechanisms [17]. Understanding the role of participants
within the system as well as in the participatory modelling process and bridging professional cultures [45] is
key to understanding the factors that will impact on the
uptake of simulation modelling as an evidence synthesis
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tool. Participatory modelling approaches aim to combine
multidisciplinary stakeholder perspectives to tackle the
social complexity of problems and recognise that different types of knowledge contribute alternative and valuable perspectives to the problem discourse [33].
Evaluation of the participatory simulation modelling
process in the health sector has been lacking [5, 41] despite assessment of its efficacy being essential to inform
decision-making [5, 37]. Understanding the intricacies of
the participatory process [33] and evaluating methods
and tools to facilitate participatory modelling is necessary to improve modelling outcomes [4, 31, 37] and further research is required to develop and refine rigorous
evaluation methods [39]. The Challenge and Reconstruct
Learning (CHaRL) Framework has been proposed by
Smajgl and Ward [46] to evaluate participatory modelling processes. This framework can be used for deliberative approaches [47] and involves assessing formalised
and facilitated learning among decision-makers and decision influencers at varied policy levels. The key component
of the CHaRL framework is the change in perception or
belief about assumed causality within the system. In other
words, participants’ mental models are challenged by the
presentation of different perspectives, scientific evidence
and system interactions through the modelling process.
The change in mental model can be measured using individual value and attitude/belief orientations recorded by
participants pre- and post- the modelling process [46].
Study objectives

The objectives of the research are to apply and evaluate
a simulation modelling approach, using gestational diabetes
as a case study to:
1. Pilot simulation modelling to optimise the use of
evidence to inform policy and program decision-making
by synthesising and integrating diverse evidence sources
into a dynamic simulation model of gestational diabetes
using a participatory modelling approach. The model
will be used to understand the complex interrelation of
factors that drive gestational diabetes mellitus (GDM)
rates and test options for interventions.
2. Investigate the perceived value and efficacy of
participatory simulation modelling methods as an
evidence synthesis and decision support method in
an applied health sector context.
Using GDM as a case study

GDM is a complication of pregnancy that is defined as
carbohydrate intolerance resulting in hyperglycaemia (abnormally high blood sugar) of variable severity with onset
or first recognition during pregnancy [48]. GDM defined in
this way includes women with undiagnosed pre-existing
diabetes, as well as those for whom the first onset is during
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pregnancy (especially during the third trimester of pregnancy). The prevalence of GDM is increasing both in
Australia and internationally [49].
Identified risk factors for GDM include maternal body
mass index of at least 30 kg/m2 [50–52], increasing
maternal age [52], physical inactivity [50, 52], increasing
parity, and ethnicity [53]. Women are also at increased
risk if they have a history of GDM [52], previously had a
macrosomic baby (birthweight greater than 4000 g), a
family history of diabetes [52], polycystic ovary syndrome
[52], or a diet low in fibre [54, 55].
Perinatal risks associated with GDM include macrosomia, shoulder dystocia, other birth injuries, hypoglycaemia
and perinatal mortality [53, 56]. Long-term risks for the
infant from GDM include sustained impairment of glucose tolerance [57], subsequent obesity [58] (although not
when adjusted for size) [59], and impaired intellectual
achievement [60]. For women, gestational diabetes is a
strong risk factor for the development of diabetes later in
life [61, 62].
Although the risks associated with gestational diabetes
are well recognised, debate remains as to whether
screening and treatment to reduce maternal glucose
levels reduce these risks [53, 63]. Given this uncertainty,
professional groups disagree on whether to recommend
routine screening, selective screening based on risk factors for gestational diabetes, or no screening [53]. There
is also debate over the efficacy of using a single raised
blood glucose result to diagnose GDM [63].
The Australian diagnostic threshold for GDM was changed to be consistent with WHO criteria from January 1,
2015. The WHO report from which the criteria were obtained acknowledges that the evidence for the threshold
chosen is weak. However, they argue that the benefits of
treatment, i.e. reduction of risk for macrosomia, shoulder
dystocia and pre-eclampsia is sufficient justification. Treatment of gestational diabetes once diagnosed is generally
medicalised (insulin treatment) and involves intense use of
health services, mostly in the third trimester. Investigations
of the cost implications of using the lowered diagnostic
threshold concluded that cost effectiveness will only be
achieved if treatment reduces the risk of caesarean section
birth and developing Type 2 diabetes mellitus [64, 65].
Pregnancy has been identified as a point in the life
cycle where individuals have increased motivation to
commit to health improving behaviours, for example, in
smoking cessation [66]. A diagnosis of GDM (or even a
glucose tolerance test result that approaches the diagnostic cut-off ) may provide a powerful leverage point for
multidisciplinary health interventions promoting lifestyle
change to reduce the risk of developing diabetes later in
life. Almost all women (95%) with a diagnosis of borderline GDM in an Australian study identified that managing
their borderline GDM was important or very important
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for the health of their baby and themselves [67]. Enablers
identified by women to implement lifestyle change during
pregnancy include family support [66, 67], physical access
to programs, knowledge (about diet, exercise and GDM),
and motivation levels [67].
Previous models of GDM developed to investigate the
cost effectiveness of screening and treatment regimens
[64, 65, 68, 69] have provided valuable evidence to inform decision-making. However, these models focussed
on an economic evaluation of specific treatments and
did not analyse the wider outcomes of policy and program decisions, including the intended and unintended
consequences and resource implications of interventions
delivered in the health system [70]. Dynamic simulation
modelling has been used to investigate the intergenerational impact of GDM on the development of Type 2
diabetes mellitus among First Nations and other population groups in Canada [71]. This model included representations of factors contributing to the development of
diabetes mellitus, including changes in behaviour regarding diet and physical activity over time and found that
GDM disproportionately contributed to the development of Type 2 diabetes mellitus in First Nations populations compared with other population groups [71].
Dynamic simulation modelling provides an opportunity to explore and compare the implications of health
intervention options for GDM services in the Australian
Capital Territory (ACT) and to inform policy and program decision-making. The simulations derived from the
model can be used to explore the dynamic interaction of
risk factors such as maternal weight and weight gain
(pre and during pregnancy); the impact of screening
earlier or later in pregnancy; the impact of universal or
selective screening; the impact of lowering the diagnosis
threshold on the number of women diagnosed, health
outcomes and health system impacts; the implications of
intervention options for prevention and treatment of
GDM with different target groups and with different
timings (e.g. at the start of pregnancy, during pregnancies, between pregnancies); GDM diagnosis and risk of
later development of Type 2 diabetes in the ACT; and
the short- and long-term outcomes for mother and baby
following treatment for GDM.
The current research project will contribute to knowledge on the application of systems thinking to a localised
health system case study by undertaking, validating and
evaluating a participatory simulation modelling process
focusing on GDM.

Methods/Design
Design overview

The study design will use mixed methods to achieve the
research objectives. A participatory simulation modelling
approach will be used to synthesise evidence and explore
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strategies for GDM diagnosis, early intervention and management (Objective 1). Evaluation of the modelling process
as a systems-based knowledge synthesis tool will incorporate both qualitative and quantitative methods (Objective 2).
Research questions

Simulation modelling will be used to answer the following
research questions about GDM interventions in the ACT.
Model simulations will explore:
 The dynamic interaction between risk factors such







as pre-pregnancy maternal weight, maternal weight
gain during pregnancy, GDM diagnosis and life-time
risk of developing of Type 2 diabetes for mothers
and babies in the ACT
The short- and long-term outcomes for mother and
baby following treatment for GDM in the ACT
The impact of changing the diagnosis threshold on
the number of women diagnosed, health outcomes
and the health system impacts (including health
economic analysis)
Health outcomes achieved from priority interventions
identified by participants
Cost effectiveness of priority interventions identified
by participants

This research will also explore the effectiveness of
participatory simulation modelling methods to optimise
the use of evidence to inform policy and program decisionmaking through qualitative and quantitative methods investigating the participatory modelling process and evidence of
impact on decision-making (detailed further below). The
specific questions to be answered by this research include:
 Whether simulation modelling is an effective tool to

facilitate evidence-informed decision-making in an
applied health setting
 The efficacy of applying a participatory approach to
model development
 The benefits and limitations of using simulation
modelling to explore potential outcomes from a
range of policy and intervention options to inform
decision-making
Study setting

The study is being conducted as part of an ongoing initiative of The Australian Prevention Partnership Centre
to apply systems approaches to the prevention of chronic
disease. The research will be carried out at the ACT
Government Health Directorate, which provides publicly
funded health services for a population of approximately
390,000 in the ACT and is the major health referral centre
for the Greater Southern Region of NSW. The total catchment area population is over 600,000 people. Tertiary level
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maternity services are provided by Canberra Hospital at the
Centenary Hospital for Women. There are two publicly
funded hospitals and one private hospital in the ACT,
providing maternity services.
The number of women giving birth in the ACT is over
6000 per year. Approximately 15% of these women are
not ACT residents but access services in the ACT for high
risk pregnancy complications (i.e. requiring tertiary level
care). There a number of models of antenatal maternity
care provided in the ACT including hospital-based outpatient care, tertiary level care, private midwifery care, and
shared care (which is integrated with primary healthcare
providers).
A specialist gestational diabetes service with satellite
clinics in community health centres works with generalist maternity services to provide education and health
services for women with gestational diabetes.
Participants

Purposive sampling will be used to recruit participants
with a range of expertise such as endocrinology, obstetrics,
neonatology, diabetes education, nursing, midwifery, policy,
health economics, exercise physiology, pathology, public
health, research, allied health, health service management,
consumers (healthcare recipients) and the simulation modelling expert team. The anticipated number of participants
is 10 to 15 to allow for wide engagement with influential
leaders while maintaining a manageable dialogue with
meaningful contributions from all members.
The inclusion criteria for participants is that they are
recognised experts in providing care, planning services,
undertaking research or developing policy for the diagnosis and management of GDM. Participants must also
be willing to attend model development and application
sessions and participate in the evaluation.
Participants in the group model building and model
validation processes will be asked to provide written
consent prior to participating.
Procedure
Objective 1 – Participatory model development

Model development This research will employ a participatory simulation modelling process, which will involve
the following steps [4, 26, 31, 36]:
 Forming an expert sub-group of the participants

listed above who will define the boundaries of the
model. A model is not able to include in detail every
possible factor, relationship and intervention, and
therefore only those that are relevant to the policy
and practice questions to be answered by the model
should be included in the first instance. Engaging
with the literature and collaborating with stakeholders
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and researchers to understand the risk factors for
GDM, options for GDM diagnosis and intervention,
and reach agreement on the priority health and
economic outcome indicators to be included in the
model structure
Identifying data sources and populating the model
with data (parameterising the model)
Deciding which local and/or national data on current
practices and behaviours should be incorporated into
the model
Identifying potential intervention leverage points
and mapping the mechanism by which interventions
have their effect in the model
Validating the model using accepted validation
methods such as assessment of face validity, system
behaviour reproduction, parameter estimation,
sensitivity analysis and statistical testing [41]
As the model develops into a functioning simulation
tool, exploring possible scenarios and prediction of
outcomes
Ensuring the purpose, assumptions and limitations
of the model are clearly stated
Using the final model to explore the timing,
frequency and combination of interventions that
deliver optimal impact

The participatory model development process will
identify the factors to be represented in the model. It is
anticipated that a combination of high level aggregated,
individual characteristics and interactions and eventbased factors (e.g. service utilisation), will be identified.
Therefore, a more flexible hybrid modelling approach
will be adopted incorporating system dynamics, agentbased and discrete event modelling methods.
System dynamics modelling methods were created in
the 1950s by Jay Forrester in the field of engineering.
System dynamics modelling utilises feedback loops (causal
loop diagrams) and stock (accumulations) and flow diagrams to represent complex systems [6, 23, 72]. This modelling method represents the dynamics of the system at a
high level of abstraction [6], making them an efficient form
of modelling in terms of computing resources. System
dynamics simulates patterns and trends in system behaviour. Simulation experiments can be used to compare and contrast intervention alternatives to inform
decision-making [70].
Agent-based modelling (ABM) methods have been
developed more recently and allow for representation
of individuals or agents within the system. The model
can be built from the ground up by defining agents,
their behaviours and their interactions [6, 72]. ABM is
a computational method used to examine the actions of
agents (e.g. individuals) situated in an environment (e.g.
neighbourhood). ABMs specify decision rules controlling
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dynamics such as ‘If–Then’ statements and mechanistic
interactions among agents. When the program is run,
agents interact with one another and their environment, often resulting in counterintuitive insights about
behaviour of agents and the system [23]. Incorporating
ABM components allows flexibility to incorporate the
dynamics of people making decisions affecting population
health outcomes, and thus efficient planning of healthcare
interventions [70].
Discrete event modelling methods represent the system
as a process, namely, as a sequence of operations or events
performed across entities [72]. For example, discrete event
methods are frequently used to represent and improve efficiency of health services such as emergency departments.
This modelling method represents complex systems at a
low level of abstraction. The core concepts in discrete
event simulation (DES) are events, entities, attributes and
resources. An event happens at a certain time point in the
environment and can affect resources and/or entities.
Entities have attributes and consume resources while experiencing events, but consumption is not affected by
individual-level behaviour. Attributes are features or characteristics unique to an entity. They can change over time
or not. Resources are objects that provide a service to an
entity. Queues are another important concept in DES and
occur when several entities compete for a specific resource for which there is a constraint [70]. DES modelling is useful to analyse resource utilisation, throughput
of services and the impact of varying policy decisions [70].
Advances in modelling software technology now enable multiple modelling methods to be integrated [72].
This allows for modellers to represent the many interacting components of a system and the complex interplay between individual behaviour and social connections across
populations [6].
Model application Once the model develops into a
functioning simulation tool it will be used to explore
possible scenarios and prediction of outcomes. During
this phase, a broader stakeholder group will be formed
and engaged in policy/strategy dialogues facilitated by
interaction with the model and explore the costs and
benefits for a range of intervention options. The composition of the stakeholder group will include the full
scope of disciplines and consumers outlined in the Participants section. The model application process aims to
refine the model as well as to demonstrate the utility of
the model to key decision-makers so as to inform policy
action and program decisions.
The transdisciplinary simulation modelling process
provides an opportunity to establish network relationships
and analyse policy and program options based on outcomes
simulated. An action statement regarding GDM diagnosis
and treatment in the ACT based on the simulation
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modelling work and synthesised evidence will be developed with the expert group.
Data analysis The model will be built using AnyLogic®
7.2, St Petersburg, Russian Federation. AnyLogic® software allows for multiple modelling methods to be integrated into a single hybrid model providing participants
both flexibility and transparency in model design.
Model parameterisation involves populating the model
with data and will evolve in accordance with the participatory modelling process. This will make use of the following:
 Secondary analysis of de-identified administrative








data to inform transitions (hazard rates/probabilities/
relationships between risk factors) within the model
structure. For example, regression analyses may be
conducted to determine the contribution of gestational
diabetes in relation to other risk factors to perinatal
outcomes such as birthweight
Published demographic information such as age
and gender characteristics, age-specific fertility
rates, population estimates of weight status categories
Published results from research on intervention
effects such as the impact of targeted pregnancy
weight management programs focused on nutrition
or physical activity on the development of GDM
Local expert knowledge to supplement available data
Partitioned administrative and/or available survey
data to calibrate the model

Statistical analysis of administrative data will be conducted using IBM SPSS Statistics version 22, United States.
Data availability is a potential limitation to this study.
It is proposed that, where data is not of high quality or
is not available, placeholder values will be used and
tested using the following methods. Firstly, the model
simulations will be analysed against trends and patterns
observed in historical data and, secondly, sensitivity testing will be conducted around the missing values to determine if the model outputs depend significantly on them.
When parameters are identified that the model is sensitive
too, this can be used to guide and prioritise future research activities to obtain these important pieces of data.
Assumptions surrounding the use of placeholder values
will be made explicit in descriptions of the methods used
to develop the model.
Validation of the model is necessary to assess the logic,
soundness and utility of the model outputs [41]. Validation of the model can be conducted as part of the model
development process by conducting tests and involving
the model users in assessing the validity of the model [73].
The model will be validated using accepted validation
methods such as assessment of face validity, system behaviour reproduction, parameter estimation, sensitivity analysis
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and statistical testing [41]. Expert participants in the model
development process will be asked to assess whether the
model and its behaviour and outputs are reasonable given
their knowledge of the system [73]. The model behaviour
will also be tested against historical data and model
simulations over time will be assessed. Available data
will be partitioned with a subset used to build the
model and the remaining data used to determine (or
test) whether the model replicates the historical system
behaviour [73]. Parameter variability and sensitivity
analyses will also be conducted to test model behaviour
and to determine which parameters the model is most
sensitive too. Those parameters that are sensitive, that
is they cause significant changes in the model’s behaviour
or output, should be made sufficiently accurate prior to
using the model [73].
Objective 2 – Evaluation of a participatory approach to
dynamic simulation model building

Procedure The case study methodology allows for investigation of the strengths, weaknesses and evaluation
of participatory simulation modelling as a mechanism to
influence policy and program decision-making and develop
action statements [2]. Little is known about the value,
strengths and limitations of simulation modelling as applied
to ‘real world’ health policy decision-making. The key
research questions addressed in this study include those relating to engagement of experts in the process; perceived
commitment, influence and confidence of stakeholders in
implementing policy and program decisions identified in
the modelling process; and measuring the impact of the
process in terms of policy and program change.
The evaluation of the participatory modelling process is
informed by the CHaRL Framework proposed by Smajgl
and Ward [46]. The CHaRL framework can be used for deliberative approaches and involves assessing formalised and
facilitated learning among decision-makers and decision
influencers at varied policy levels. The key component of
the CHaRL framework is the change in perception or belief
about assumed causality within the system. In other words,
participants’ mental models are challenged by the presentation of different perspectives, scientific evidence and system
interactions through the modelling process. The change in
mental model can be measured using individual value and
attitude/belief orientations recorded by participants before
and after the modelling process [46].
Therefore, the evaluation methods to determine the
effectiveness and impact of systems dynamic modelling
will include investigating the:
 Participation in the process, e.g. response rate to

invitations, attendance and retention at modelling
sessions and subsequent deliberative forums
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 Participants’ perceptions of the key factors that

contribute to GDM and the best use of resources to
diagnose and manage GDM through survey responses
 Group interactions, contributions and engagement with
the process by qualitative analysis of audio recordings of
the model building and engagement sessions
 Informant views via semi-structured interview on the:
 value of simulation modelling as an evidence
synthesis tool
 strengths and limitations and intention to use
simulation modelling in the future
 perceived enablers and barriers to the use of
simulation modelling
 personal response to the participatory modelling
process
 Follow-up environment scan to determine policy
and program decisions that were informed by the
modelling process and the model outputs
Data analysis Quantitative analyses will include measuring and reporting the number of sessions attended, and
analysing the responses recorded on the before and after
forum surveys.
Participants will be asked to record their views on the
main contributing factors to GDM, the optimal time for
screening for GDM and how they would allocate resources
to a hypothetical new service for women with GDM. They
will also be asked to provide self-reported evaluation feedback reflecting on their learning and ways to improve the
modelling sessions.
Qualitative analyses will include analysing the data collected during:
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The main domains to be covered will include participant’s perceptions or ‘mental model’ of GDM through
the modelling process, value of simulation modelling as
an evidence synthesis methodology to inform decisionmaking, and intention to use this method in the future.
The proposed interview questions are contained in Box 1.
Box 1 Semi-structured interview questions to obtain
key informant views
Prior to workshops
Based on your experience, what are the current challenges that
GDM services are facing? What do you think is driving these
challenges? What changes do you think GDM services need to
make to cope with these challenges? Which interventions would
you prioritise to prevent and manage GDM?
Could you talk a little about your thoughts on evidencebased decision-making in the health policy context? To what extent do you think evidence is used to inform health policy and
program decisions? What factors have you found to be
useful to support its use? What are the main challenges?
Have you had experience using results of evidence synthesis
methods such as systematic reviews, meta-analyses? Did they meet
your needs for evidence to inform your decision-making? From your
experience, what are the strengths and limitations of these methods?
What other forms of evidence do you use in decision-making?
Have you participated in any form of simulation modelling process
before? (If reply yes) Could you tell me about the modelling process
and your experience of it? In your opinion, what are the benefits and
limitations of simulation modelling as an evidence synthesis tool?
Post workshops

1. Model development sessions
2. Model application sessions
3. Semi-structured interviews (pre- and post-modelling
workshops)
4. Notes and memos based on meetings and de-identified
conversations with participants and the modelling team

Could you tell me about your experience of participating in the
simulation modelling process? What are the strengths and
weaknesses of simulation modelling as an evidence synthesis tool?
Has/How has the modelling process influenced your opinion
of the key factors that contribute to GDM? Has/How has the
modelling process influenced your opinion of the best use of

The model development and application sessions will
be audio recorded, primarily to allow the investigators to
review content information and expert advice provided
by participants relating to model development. The recordings, participant observations and field notes will be
kept to highlight particularly valuable comments and
analyse behaviours or interactions between participants.
The analysis of field notes will be triangulated against
the audio recordings and interview transcripts.
Semi-structured interviews will be conducted with
participants of the model development and model application sessions. Participants will be purposively selected
for interviews to provide a range of perspectives and interviews will be conducted face-to-face where possible.

resources to screen for and treat GDM?
Will you use the outcomes of the gestational diabetes modelling
process to guide your future decision-making? Why or why not?
Based on your experience would you say simulation modelling is
worthwhile for health sector policy/practice settings? Why/why not?
Do you intend to use the outputs of this model or participate in
other simulation modelling projects in the future? Why or why not?
In your opinion, what would you say are facilitators and
barriers to the use of simulation modelling to synthesise
evidence for decision-making?
Do you have any recommendations to improve the process
for using simulation modelling as an evidence synthesis tool?
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Field notes relating to meetings and informal discussions will be maintained by the researcher in a journal
format and will be included in the qualitative data analysis.
>Audio recordings will be transcribed and integrated
with field notes and reflections. Transcriptions will be
de-identified, collated and coded so that only general
themes emerge.
Interview data will be independently coded by two investigators. Initial codes will be derived from the research aims and subsequently refined over two coding
cycles. The two coders will compare and agree upon
codes and emerging themes at the end of each cycle, resolving disagreement by consensus opinion or by the
creation of new, mutually agreeable, codes/themes.
Data analysis will be iterative and begin with identifying central organising concepts, patterns and themes
from the coded data. Thematic analysis will be reflective
and revised by revisiting the coded and collated data to
ensure that identified themes and subthemes are coherent,
distinctive and relevant to the research question [74].
Common and repeated themes identified from the modelling sessions will be investigated through interviews to
better understand informant views in relation to specific
topics, and to assess the strength and importance of various
themes. A comparative analysis will be conducted to understand the range of participant views in relation to their role
perspective and level of power within their organisation,
e.g. clinician, researcher, manager and policymaker views.
This research involves investigators who currently work
within the local health sector. This provides some advantage
as these investigators have good knowledge of the system and
context; however, it also presents challenges and limitations.
For example, the investigators’ willingness to identify and report on system limitations may be impacted by their professional affiliation with the organisation. The involvement of
external co-investigators and the use of independent reporting
mechanisms through The Australian Prevention Partnership
Centre are mitigation strategies to be employed for this challenge. The use of voluntary recruitment processes and confidentialised analyses of individual input and participation will
be employed to address perceptions of coercion or concerns
of repercussion from either participating or declining to participate in this research.
A follow-up environment scan to determine policy
and program decisions that were informed by the modelling process and the model outputs will be conducted
three to 3–6 months after the model engagement workshops. This will involve interviews with end users and
document analyses to determine the use of model outputs to inform decision-making.
Data storage and management

All audio-recorded data from the model development
and model application sessions will be de-identified by
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using codes instead of names and removing any potentially
identifying text from transcripts. Data will be stored
securely on password protected computers or ACT
Health secure servers and will only be accessible to the
researchers.
Paper surveys will be anonymised and scanned to create an
electronic file to be stored in secure folders on a secure server
only accessible to the researchers. The paper surveys will then
be securely destroyed. Clinical and administrative data to be
used for the project will be de-identified prior to analysis.

Discussion
This project will apply systems science and simulation
modelling to GDM in the ACT as a case study.
The outcomes will include, firstly, producing a model
that will be a functioning simulation tool to explore possible scenarios and the impact of those scenarios on health
outcomes for the mother and baby as well as service impacts for the health system; secondly, developing a joint
commitment for policy action and program decisions
through engagement with the stakeholder group and,
thirdly, evaluating the use of simulation modelling to
inform decision-making.
The participatory model-building process will be informed by a multidisciplinary expert stakeholder group.
This provides an opportunity to ensure the model reflects the shared understanding of the causal pathways
and potential intervention points in the system.
Simulation modelling methods will be used to explore
and compare strategies for GDM diagnosis, early intervention and management. The modelling will include interaction between risk factors, the short- and long-term
outcomes for mother and baby, and potential modes and
timing of intervention.
Importantly, involving key decision-makers and experts
in the model development and validation process increases the acceptability of the model for the local context.
The model is therefore more likely to be useful to inform
decisions about priority interventions and policies.
Systems science is emerging as an effective way to examine both complex health problems and their context. It can
be used to synthesise evidence, examine and compare potential outcomes of policy options, and guide the best use
of limited resources through methods such as simulation
modelling. This research will contribute to existing knowledge, firstly, by applying a participatory process to simulation modelling in a local health setting; the participatory
process will engage expert stakeholders in the development
of a functioning model to inform decision-making. Secondly, by developing and incorporating evaluation methods
to investigate the efficacy of simulation modelling as an evidence synthesis tool. Thirdly, by using quantitative data to
develop a simulation model to inform health policy and
program decisions.
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